Application of in vitro cell transformation assays to predict the carcinogenic potential of chemicals

Mutation Research - Reviews in Genetic Toxicology

Volumn 365, Issue 1-3, 1996, Pages 161-173

  Isfort, Robert J ^a   LeBoeuf, Robert A ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

ANIMAL CELL; CANCER RISK; CARCINOGEN TESTING; CARCINOGENESIS; CELL TRANSFORMATION; GENOTOXICITY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALIA; RODENTIA;

EID: 0030250780     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1110(96)90019-6     Document Type: Article

References (84)

1. Aardema M.J., Isfort R.J., Thompson E.D., LeBoeuf R.A. The low pH Syrian hamster embryo (SHE) cell transformation assay: a revitalized role in carcinogen prediction. Mutation Res. 1996;. in press.
2. Aaronson S.A., Todaro G.J. Development of 3T3-like lines from BALB / c mouse embryo cultures: transformation susceptibility to SV40. J. Cell Physiol. 72:1968;141-148.
3. Aaronson S.A., Todaro G.J. Basis for the acquisition of malignant potential by mouse cells cultivated in vitro. Science. 162:1968a;1024-1026.
4. Ashby J., Tennant R.W. Definitive relationship among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutation Res. 257:1991;229-306.
5. Barrett J.C., Hesterberg T.W., Thomassen D.G. Use of cell transformation systems for carcinogenicity testing and mechanistic studies of carcinogens. Pharm. Rev. 36:1984;53S-70S.
6. Barrett J.C., Elmore E. Comparison of carcinogenesis and mutagenesis of mammalian cells in culture. Flamm W.G., Lorentzen R.J., Mehlman M.A. Advances in Modern Environmental Toxicology, Vol. 12: Mechanisms of Toxicity of Chemical Carcinogens and Mutagens. 1985;171-206 Princeton Scientific Publishing Co. Princeton, NJ.
7. Barrett J.C. Cellular and molecular mechanisms of multistep carcinogenesis in cell culture models. Barrett J.C. Mechanisms of Environmental Carcinogenesis: Multistep Models of Carcinogenesis. Vol. 1:1987;129-142 CRC Press, Inc. Boca Raton, FL.
8. Barrett J.C., Fletcher W.F. Cellular and molecular mechanisms of multi-step carcinogenesis in cell culture models. Barrett J.C. Mechanisms of Environmental Carcinogenesis: Multistep Models of Carcinogenesis. Vol. 2:1987;73-116 CRC Press, Inc. Boca Raton, FL.
9. Berwald Y., Sachs L. In vitro transformation with chemical carcinogens. Nature. 200:1963;1182-1184.
10. Bishop J.M. Molecular themes in oncogenesis. Cell. 64:1991;235-284.
11. Boyd J.A., Barrett J.C. Genetic and cellular basis of multistep carcinogenesis. Pharmacol. Ther. 46:1990;469-486.
12. Butterworth B.E. Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential. Mutation Res. 239:1990;117-132.
13. Cha R.S., Thilly W.G., Zarbl H. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hrasl gene mutations. Proc. Natl. Acad. Sci. USA. 91:1994;3749-3753.
14. Cohen S.M., Ellwein L.B. Cell proliferation in carcinogenesis. Science. 249:1990;1007-1011.
15. Cross M., Dexter T.M. Growth factors in development, transformation and tumorigenesis. Cell. 64:1991;271-280.
16. DiPaolo J.A., Takano K., Popescu N.C. Quantitation of chemically-induced neoplastic transformation of BALB/3T3 cloned cell lines. Cancer Res. 32:1972;2686-2695.
17. Dunkel V.C., Swiernga S.H.H., Brillinger R.L., Gilman J.P.W., Nestman E.R. Recommended protocols based on a survey of current practice in genotoxicity testing laboratories: III. Cell transformation in the C3H 10T1/2 mouse embryo cells, BALB/c 3T3 mouse fibroblasts and Syrian hamster embryo cell cultures. Mutation Res. 246:1991;285-300.
18. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
19. Forrester K., Kispert J., Sanchez J.H., Gerwin B.I., Tisty T.D., Harris C.C. Clonal variation of tumorigenic potential in v-Ha-ras transformed human bronchial epithelial cells: relationship to ras oncogene expression and CAD gene amplification. Mol. Carcinogen. 11:1994;34-41.
20. Gibson D.P., Aardema M.J., Kerckaert G.A., Carr G.J., Brauninger R.M., LeBoeuf R.A. Detection of aneuploidy-inducing carcinogens in the Syrian hamster embryo (SHE) cell transformation assay. Mutation Res. 343:1995;7-24.
21. Hao Y., Crenshaw T., Moulton T., Newcomb E., Tycko B. Tumor suppressor activity of H19 RNA. Nature. 365:1993;764-767.
22. Haseman J.K., Zeiger E., Shelby M.D., Margolin B.H., Tennant R.W. Predicting rodent carcinogenicity from four in vitro genetic toxicity assays: an evaluation of 114 chemicals studied by the National Toxicology Program. J. Am. Stat. Assoc. 85:1990;964-971.
23. Hei T.K., Piao C.Q., Willey J.C., Thomas S., Hall E.J. Malignant transformation of human bronchial epithelial cells by radon-simulated alpha particles. Carcinogenesis. 15:1994;431-437.
24. Heidelberger C., Freeman A.E., Pienta R.J., Sivak A., Bertran J.A., Casto B.C., Dunkel V.C., Francis M.C., Kakunaga T., Little J.B., Schechtman L.M. Cell transformation by chemical agents: a review and analysis of the literature. Mutation Res. 114:1983;283-385.
25. Hennings H., Glick A.B., Greenhalgh D.A., Morgan D.A., Strickland J.E., Tannenbaum T., Yupsa S.H. Critical aspects of initiation, promotion and progression in multistage epidermal carcinogenesis. PSEBM. 202:1993;1-18.
26. Hesterberg T.W., Barrett J.C. Induction by asbestos fibers of anaphase abnormalities: mechanisms for aneuploidy induction and possibly carcinogenesis. Carcinogenesis. 6:1985;473-475.
27. Hollstein M., McCann J., Angelosant F.A., Nichols W.W. Short term test for carcinogens and mutagens. Mutation Res. 65:1979;289-356.
28. Isfort R.J., LeBoeuf R.A. The Syrian hamster embryo (SHE) cell transformation system: a biologically relevant in vitro model - with carcinogen predicting capabilities - of in vivo multistage neoplastic transformation. Crit. Rev. Oncogen. 1996;. in press.
29. Isfort R.J., Kerckaert G., Anderson N.L., LeBoeuf R.A. Two-dimensional gel electrophoresis analysis of Syrian hamster embryo cells: morphological transformation is not cell type specific. Electrophoresis. 13:1992;855-861.
30. Isfort R.J., Cody D.B., Asquith T.N., LeBoeuf R.A. Phenotypic differences between Syrian hamster embryo cells cultured at pH 6.7 or 7.3. In vitro Cell. Dev. Biol. 28A:1992a;635-642.
31. Isfort R.J., Cody D.B., Asquith T.N., Ridder G.M., Stuard S.B., LeBoeuf R.A. Induction of protein phosphorylation, protein synthesis, immediate early gene expression and cellular proliferation by intracellular pH modulation. Eur. J. Biochem. 213:1993;349-357.
32. Isfort R.J., Cody D.B., Kerckaert G.A., LeBoeuf R.A. Growth factor responsiveness and alterations in growth factor homeostasis in Syrian hamster embryo cells during in vitro transformation. Carcinogenesis. 15:1994;1203-1209.
33. Isfort R.J., Cody D.B., Doersen C.-J., Kerckaert G.A., LeBoeuf R.A. Alterations in cellular differentiation, mitogenesis, cytoskeleton and growth characteristics during Syrian hamster embryo cell multistep in vitro transformation. Int. J. Cancer. 59:1994a;114-125.
34. Isfort R.J., Kerckaert G.A., LeBoeuf R.A. Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays to predict the carcinogenic potential of chemicals. Mutation Res. 1996a;. in press.
35. Isfort R.J., Kerckaert G.A., Cody D.B., Carter J., Driscoll K.E., LeBoeuf R.A. Isolation and biological characterization of morphological transformation sensitive Syrian hamster embryo cells. Carcinogenesis. 1996b;. in press.
36. Isfort R.J., Stuard S.B., Cody D.B., Ridder G.M., LeBoeuf R.A. Modulation of the platelet-derived growth factor induced calcium signal by extracellular/intracellular pH in Syrian hamster embryo cells. Eur. J. Biochem. 234:1996c;801-810.
37. Isfort R.J., Cody D.B., Kerckaert G.A., Stuard S.B., Tycko B., Ridder G.M., LeBoeuf R.A. Morphological transformation in Syrian hamster embryo (SHE) cells results from a block in cellular differentiation mediated by the tumor suppressor gene H19. Proc. Natl. Acad. Sci. USA. 1996d;. submitted.
38. Jones C.A., Huberman E., Callahan M.F., Tu A., Hallowell W., Pallota S., Sivak A., Lubet R.A., Avery M.D., Kouri R.E., Spalding J., Tennant R.W. An interlaboratory evaluation of the Syrian hamster embryo cell transformation assay using eighteen coded chemicals. Toxicol. In Vitro. 2:1988;103-116.
39. Kakunaga T. A quantitative system for assay of malignant transformation by chemical carcinogens using a clone derived from BALB/3T3. Int. J. Cancer. 12:1973;463-473.
40. Kawashima K., Jahan I., Fushimi K., Mihara K., Namba M. Human fibroblast (KMST-6/RAS cell line) transformed with 60Co gamma-rays and c-Ha-ras oncogene produce a large amount of granulocyte colony-stimulating factor (G-CSF); production is enhanced by cAMC, theophylline, and butyrate. Cell Struct. Funct. 20:1995;41-45.
41. Kennedy A.R., Krinsky N.I. Effects of retinoids, beta-carotene, and canthaxanthin on UV and X-ray-induced transformation of C3H10T1/2 cells in vitro. Nutr. Cancer. 22:1994;219-232.
42. Kerckaert G.A., Isfort R.J., Carr G.J., Aardema M.J., LeBoeuf R.A. A comprehensive protocol for conducting the Syrian hamster embryo cell transformation assay at pH 6.70. Mutation Res. 1996;. in press.
43. Kerckaert G.A., Brauninger R., LeBoeuf R.A., Isfort R.J. Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays. Environ. Health Perspect. 1996a;. in press.
44. Kerckaert G.A., LeBoeuf R.A., Isfort R.J. pH effects on the lifespan and transformation frequency of Syrian hamster embryo (SHE) cells. Carcinogenesis. 1996b;. submitted.
45. LeBoeuf R.A., Kerckaert G.A. The induction of transformed-like morphology and enhanced growth in Syrian hamster embryo cells grown at acidic pH. Carcinogenesis. 7:1986;1431-1440.
46. LeBoeuf R.A., Kerckaert G.A. Enhanced morphological transformation of early passage Syrian hamster embryo cells cultured in medium with a reduced bicarbonate concentration and pH. Carcinogenesis. 8:1987;689-697.
47. LeBoeuf R.A., Kerckaert G.A., Aardema M.J., Gibson D.P. Multistage neoplastic transformation of Syrian hamster embryo cells cultured at pH 6.7. Cancer Res. 50:1990;3722-3729.
48. LeBoeuf R.A., Lin P., Gruenstein E. Intracellular acidification is associated with enhanced morphological transformation in Syrian hamster embryo cells. Cancer Res. 52:1992;144-148.
49. LeBoeuf R.A., Kerckaert G.A., Aardema M.J., Gibson D.P., Brauninger R., Isfort R.J. The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals. Mutation Res. 1996;. in press.
50. Lee T.C., Oshimura M., Barrett J.C. Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in Syrian hamster embryo cells in culture. Carcinogenesis. 6:1985;1421-1426.
51. Marshall C.J. Tumor suppressor genes. Cell. 64:1991;313-326.
52. Matthews E.J., Spalding J.W., Tennant R.W. Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays. Environ. Health Perspect. 101:(Suppl. 2):1993;347-482.
53. Matthews E.J. Transformation of BALB/c-3T3 cells: I. investigation of experimental parameters that influence detection of spontaneous transformation. Environ. Health Perspect. 101:(Suppl. 2):1993a;277-291.
54. Matthews E.J. Transformation of BALB/c-3T3 cells: II. Investigation of experimental parameters that influence detection of benzo[a]pyrene-induced transformation. Environ. Health Perspect. 101:(Suppl. 2):1993b;293-310.
55. Matthews E.J. Transformation of BALB/c-3T3 cells: III. Development of a co-culture clonal survival assay for quantification of chemical cytotoxicity in high-density cell cultures. Environ. Health Perspect. 101:(Suppl. 2):1993c;311-318.
56. Matthews E.J. Transformation of BALB/c-3T3 cells: IV. Rank-ordered potency of 24 chemical responses detected in a sensitive new assay procedure. Environ. Health Perspect. 101:(Suppl. 2):1993d;319-345.
57. McCormick J.J., Maher V.M. Malignant transformation of mammalian cells in culture including human cells. Environ. Mol. Mutagenesis. 14:1989;105-113.
58. McCormick J.J., Maher V.M. Analysis of the multistep process of carcinogenesis using human fibroblasts. Risk Anal. 14:1994;257-263.
59. Mikalsen S.O., Ruyter B., Sanner T. Effects of hepatic peroxisome proliferators and 12-O-tetradecanoylphorbol 13-acetate on catalase and other enzyme activities of embryonic cells in vitro. Biochem. Pharmacol. 39:1990;527-535.
60. Min B.-M., Woo K.M., Baek J.-H., Lee G., Park N.-H. Malignant transformation of HPV-immortalized human oral keratinocytes by chemical carcinogens. Int. J. Oncol. 7:1995;249-256.
61. Nakazawa H., Aguelon A.M., Yamasaki H. Relationship between chemically induced Ha-ras mutation and transformation of BALB/c 3T3 cells: evidence for chemical-specific activation and cell type specific recruitment of oncogene in transformation. Mol. Carcinogen. 3:1990;202-209.
62. Nakazawa H., Aguelon A.M., Yamasaki H. Identification and quantification of a carcinogen-induced molecular initiation event in cell transformation. Oncogene. 7:1992;2295-2301.
63. Oberdorster G. Extrapolation of results from animal inhalation studies with particles to humans. Dungworth D.L., Muderly J.L., Oberdorster G. Toxic and Carcinogenic Effects of Solid Particles in the Respiratory Tract. 1994;335-354 ILSI Press, Washington, DC.
64. Olson D.C., Marechal V., Momand J., Chen J., Romocki C., Levine A.J. Identification and characterization of multiple mdm2 proteins and mdm-2-p53 protein complexes. Oncogene. 8:1993;2353-2360.
65. Parda D.S., Thraves P.J., Kuettel M.R., Lee M.-S., Arnstein P., Kaighn M.E., Rhim J.S., Dritschilo A. Neoplastic transformation of a human prostate epithelial cell line by the v-Ki-ras oncogene. Prostate. 23:1993;91-98.
66. Paraskeva C., Corfield A.P., Harper S., Hague A., Audcent K., Williams A.C. Colorectal carcinogenesis: sequential steps in the in vitro immortalization and transformation of human colonic epithelial cells. Anticancer Res. 10:1990;1189-1200.
67. Popescu N.C., Zimonjic D.B., Simpson S., DiPaolo J.A. Cumulative gene and chromosome alterations associated with in vitro neoplastic transformation of human cervical cells. Int. J. Oncology. 7:1995;279-285.
68. Rivedal E., Yamasaki H., Sanner T. Inhibition of gap junctional intercellular communication in Syrian hamster embryo cells by TPA, retinoic acid and DDT. Carcinogenesis. 15:1994;689-694.
69. Rivedal E., Sanner T. Metal salts as promoters of in vitro morphological transformation of hamster embryo cells initiated by benzo[a]pyrene . Cancer Res. 41:1981;2950-2953.
70. Ruch R.J., Klaunig J.E., Kerckaert G.A., LeBoeuf R.A. Modification of gap junctional intracellular communication by changes in extracellular pH in Syrian hamster embryo cells. Carcinogenesis. 11:1990;909-913.
71. Russo J., Calaf G., Russo I.H. A critical approach to the malignant transformation of human breast epithelial cells with chemical carcinogens. Crit. Rev. Oncogen. 4:1993;403-417.
72. Sell S., Pierce G.B. Biology of disease - maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancer. Lab. Invest. 70:1994;6-22.
73. Silingardi P., Klein J.L., Mesnil M., Yamasaki H. Growth suppression of transformed BALB/c 3T3 cells by transforming growth factor beta-1 occurs only in the presence of their normal counterparts. Carcinogenesis. 15:1994;1181-1185.
74. Tennant R.W., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., Minor R. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science. 236:1987;933-941.
75. Tennant R.W., Ashby J. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutation Res. 257:1991;229-306.
76. Tiemann F., Deppert W. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation efficiency. Oncogene. 9:1994;1907-1915.
77. Tsutsui T., Barrett J.C. Detection of non-mutagenic carcinogens using cultured Syrian hamster embryo cells. Altern. Anim. Test. Exp. 1:1991;65-73.
78. Tsutsui T., Watanabe E., Barrett J.C. Ability of peroxisome proliferators to induce cell transformation, chromosome aberrations and peroxisome proliferation in cultured Syrian hamster embryo cells. Carcinogenesis. 14:1993;611-618.
79. Tucker R.W., Barrett J.C. Decreased numbers of spindle and cytoplasmic microtubules in hamster embryo cells treated with a carcinogen, diethylstilbestrol. Cancer Res. 46:1986;2088-2095.
80. Vaziri C., Faller D.V. Repression of platelet-derived growth factor beta-receptor expression by mitogenic growth factors and transforming oncogenes in murine 3T3 fibroblasts. Mol. Cell. Biol. 15:1995;1244-1253.
81. Wade G.G., Mandel R., Ryser H.J. Marked synergism of dimethylnitrosamine carcinogenesis in rats exposed to cadmium. Cancer Res. 47:1987;6606-6613.
82. Yamasaki H., Katoh F. Further evidence for the involvement of gap-junctional intercellular communication in induction and maintenance of transformed foci in BALB/c 3T3 cells. Cancer Res. 48:1988;3490-3495.
83. Yang D., Louden C., Reinhold D.S., Kohler S.K., Maher V.M., McCormick J.J. Malignant transformation of human fibroblast cell strain MSU-1.1 by (+/-)-7β,8α- dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene , Proc. Natl. Acad. Sci. USA. 89:1992;2237-2241.
84. Zerrahn J., Deppert W., Weidemann D., Patschinsky T., Richards F., Milner J. Correlation between the conformational phenotype of p53 and its subcellular location. Oncogene. 7:1992;1371-1381.